case_images: PMC7562793_01
case_images: Magnetic resonance imaging conducted at first diagnosis showing soft tissue-masses (yellow arrows) with infiltration of the right humerus (A) and the right pleura (B).
case_images: fonc-10-585830-g001.jpg
case_images: PMC7562793_01_fonc-10-585830-g001.jpg
case_images: F1
case_images: Magnetic resonance imaging (MRI) showed a tumor mass with infiltration of the right humerus (Figure 1A) and the right pleura (Figure 1B).
case_images: FDG-Positron emission imaging at first relapse of ALCL showing hypermetabolic lesions around the spine (A) and within the right scapula (B).
case_images: fonc-10-585830-g002.jpg
case_images: PMC7562793_01_fonc-10-585830-g002.jpg
case_images: F2
case_images: FDG-Positron emission tomography (FDG-PET) revealed multiple hypermetabolic osteolytic lesions affecting the spine (Figure 2A), several ribs (Figure 2A) and the right scapula (Figure 2B).
case_images: Photographic documentation and positron emission imaging at second relapse of ALCL (A,B) and at 3 months after start of crizotinib treatment (C,D).
case_images: fonc-10-585830-g003.jpg
case_images: PMC7562793_01_fonc-10-585830-g003.jpg
case_images: F3
case_images: Physical examination revealed a red and swollen left forefoot with tenderness upon palpation (Figure 3A). Subsequent staging via FDG-PET revealed tracer uptake in the left forefoot (Figure 3B) as well as pathological lymph-nodes in the left groin. Over the course of 3 months the cutaneous lesion on the left forefoot vanished (Figure 3C), and FDG-PET-staging showed metabolic complete remission (Figure 3D).